MCAM and breast carcinoma: MCAM-overexpressing breast cancer cells exhibit increased expression of Slug and downregulation of ERα, suggesting that the MCAM/Slug/ERα axis may contribute to tamoxifen resistance in ERα-negative breast cancer [140].